"Ejaculatory disorders and α1-adrenoceptor antagonists therapy: Clinical and experimental researches"

Journal of Translational Medicine

Volumn 4, Issue , 2006, Pages

  Grasso, Marco ^a   Fortuna, Flavio ^a   Lania, Caterina ^b   Blanco, Salvatore ^a  

^a DESIO HOSPITAL   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN; TAMSULOSIN;

ADULT; AGED; ANIMAL TISSUE; BLADDER NECK; CLINICAL ARTICLE; CLINICAL TRIAL; COITUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INCIDENCE; MALE; NONHUMAN; PROSTATE; PROSTATE HYPERTROPHY; RETROGRADE EJACULATION; REVIEW; SEMEN ANALYSIS; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE RELAXATION; URINALYSIS; VAS DEFERENS;

EID: 33747440372     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-4-31     Document Type: Review

References (15)

1. Caine M, Raz S, Zeigler M: Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol 1975, 47(2):193-202.
2. Hellstrom W, Smith W, Sikka C: Effects of alpha-blockers on ejaculatory function in normal subjects. Program and abstracts of AUA Meeting; May 21-26,2005 S. Antonio, Texas. Abstract 874.
3. Kaplan SA: Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function. Urology 2004, 63:428-434.
4. Tambaro S, Ruiu S, Dessi C, Mongeau R, Marchese G, Pani L: Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance in ejaculation delay. J Pharmacol Exp Ther 2005, 312:710-717.
5. Price D, Schwinn D, Lomasney J: Identification, quantification and localization of mRNA for three distinct al-adrenergic receptor subtypes in human prostate. J Urol 1993, 150:546-551.
6. Djavan B, Marberger M: A meta-analysis on the efficacy and tolerability of al-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol 1999, 36:1-13.
7. Djavan B, Chapple C, Shirin Milani, Marberger M: State of art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology 2O04, 64:1081-1088.
8. Brannigan RE: Ejaculatory disorders and lower urinary tract symptoms. Curr Urol Rep 2004, 5(4):280-6.
9. Giuliano F, Bernabe J, Droupy S. Alexandre L, Allard J: A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats. BJU Int 2004, 93(4):605-8.
10. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O'Leary MP, Puppo P, Robertson C, Giuliano F: Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003, 44(6):637-49.
11. Li Mklr, Rosen R Jr: LUTS and male sexual dysfunction in Asia. J Urol 2004, 171:231.
12. Buyukafsar K, Levent A, Ark M: Expression of Rho-kinase and its functional role in the contractile activity of the mouse vas deferens. Br J Pharmacol 2003, 140(4):743-9.
13. Hampel C, Dolber PC, Smith MP, Savic SL, Th roff JW, Thor KB, Schwinn DA. Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction. J Urol 2002, 167(3):1513-21.
14. Lepor H, Tang R, Meretyk S, Shapiro E: Alpha 1 adrenoceptor subtypes in the human prostate. J Urol 1993, 149(3):640-2.
15. Park SY, Lee MY, Keum EM, Myung SC, Kim SC: Ionic currents in single smooth muscle cells of the human vas deferens. J Urol 2004, 172(2):628-33.